Cytochemical localization of beta-lipoproteins and their components in successive stages of hyperlipidemic atherogenesis of rabbit aorta.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 2597227)

Published in Atherosclerosis on October 01, 1989

Authors

R Mora1, F Lupu, N Simionescu

Author Affiliations

1: Institute of Cellular Biology and Pathology, Bucharest, Romania.

Articles by these authors

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell (1999) 7.33

Galloylglucoses of low molecular weight as mordant in electron microscopy. I. Procedure, and evidence for mordanting effect. J Cell Biol (1976) 5.27

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet (2001) 4.66

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med (1999) 4.33

Permeability of muscle capillaries to small heme-peptides. Evidence for the existence of patent transendothelial channels. J Cell Biol (1975) 3.42

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet (1997) 3.40

Permeability of intestinal capillaries. Pathway followed by dextrans and glycogens. J Cell Biol (1972) 2.80

Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis. J Cell Biol (1986) 2.73

Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost (2005) 2.70

Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med (2001) 2.66

Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites. J Cell Biol (1981) 2.27

Differentiated microdomains on the luminal surface of capillary endothelium: distribution of lectin receptors. J Cell Biol (1982) 2.23

Segmental differentiations of cell junctions in the vascular endothelium. The microvasculature. J Cell Biol (1975) 2.22

Differentiated microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites. J Cell Biol (1981) 2.18

Cellular aspects of transcapillary exchange. Physiol Rev (1983) 2.10

Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol (1996) 2.08

Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol (2001) 2.06

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation (1997) 1.91

Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J Cell Biol (1983) 1.86

Permeability of muscle capillaries to exogenous myoglobin. J Cell Biol (1973) 1.79

Structural aspects of the permeability of the microvascular endothelium. Acta Physiol Scand Suppl (1979) 1.77

Morphometric data on the endothelium of blood capillaries. J Cell Biol (1974) 1.62

Dextrans and glycogens as particulate tracers for studying capillary permeability. J Cell Biol (1971) 1.56

Hyperexcitability of convergent colon and bladder dorsal root ganglion neurons after colonic inflammation: mechanism for pelvic organ cross-talk. Neurogastroenterol Motil (2006) 1.51

Structural basis of permeability in sequential segments of the microvasculature of the diaphragm. II. Pathways followed by microperoxidase across the endothelium. Microvasc Res (1978) 1.50

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol (1998) 1.48

Preferential distribution of anionic sites on the basement membrane and the abluminal aspect of the endothelium in fenestrated capillaries. J Cell Biol (1982) 1.47

Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol (1986) 1.45

Rings of membrane sterols surround the openings of vesicles and fenestrae, in capillary endothelium. J Cell Biol (1983) 1.40

Inflammation, innate immunity and blood coagulation. Hamostaseologie (2010) 1.39

Galloylglucoses of low molecular weight as mordant in electron microscopy. II. The moiety and functional groups possibly involved in the mordanting effect. J Cell Biol (1976) 1.38

Histamine receptors of the microvascular endothelium revealed in situ with a histamine-ferritin conjugate: characteristic high-affinity binding sites in venules. J Cell Biol (1982) 1.31

In vivo detection of c-Met expression in a rat C6 glioma model. J Cell Mol Med (2007) 1.25

Innate immunity and coagulation. J Thromb Haemost (2011) 1.24

Organization of cell junctions in the peritoneal mesothelium. J Cell Biol (1977) 1.21

Isolation and characterization of endothelial cells from the heart microvasculature. Microvasc Res (1978) 1.20

Segmental differentiations of cell junctions in the vascular endothelium. Arteries and veins. J Cell Biol (1976) 1.19

Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res (2000) 1.18

Open junctions in the endothelium of the postcapillary venules of the diaphragm. J Cell Biol (1978) 1.16

Differentiated microdomains of the luminal plasmalemma of murine muscle capillaries: segmental variations in young and old animals. J Cell Biol (1985) 1.12

Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol (1997) 1.11

Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology. Cell Biol Rev (1991) 1.11

An endothelial storage granule for tissue-type plasminogen activator. J Cell Biol (1997) 1.10

Identification of albumin-binding proteins in capillary endothelial cells. J Cell Biol (1988) 1.10

Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology. Cell Biol Rev (1991) 1.09

Endothelial albumin binding proteins are membrane-associated components exposed on the cell surface. J Biol Chem (1989) 1.08

Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res (2000) 1.08

Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol (2000) 1.07

Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. Arterioscler Thromb Vasc Biol (1999) 1.06

Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res (1997) 1.06

Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol (1995) 1.03

Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J Cell Biol (1998) 1.03

Binding and transcytosis of glycoalbumin by the microvascular endothelium of the murine myocardium: evidence that glycoalbumin behaves as a bifunctional ligand. J Cell Biol (1988) 1.03

Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes. Arterioscler Thromb Vasc Biol (2000) 0.99

Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood (2000) 0.99

Development of intracellular lipid deposits in the lipid-laden cells of atherosclerotic lesions. A cytochemical and ultrastructural study. Atherosclerosis (1987) 0.97

Adipose tissue expression of gelatinases in mouse models of obesity. Thromb Haemost (2001) 0.96

Distinct localization and function of (1,4,5)IP(3) receptor subtypes and the (1,3,4,5)IP(4) receptor GAP1(IP4BP) in highly purified human platelet membranes. Blood (2000) 0.95

Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol (1997) 0.95

Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost (2006) 0.94

Structural basis of permeability in sequential segments of the microvasculature of the diaphragm. I. Bipolar microvascular fields. Microvasc Res (1978) 0.93

Ultrastructural evidence of differential solubility in Triton X-100 of endothelial vesicles and plasma membrane. Exp Cell Res (1995) 0.92

Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells. Eur J Cell Biol (1993) 0.91

Release of soluble urokinase receptor from vascular cells. Thromb Haemost (2001) 0.91

Biochemically differentiated microdomains of the cell surface of capillary endothelium. Ann N Y Acad Sci (1982) 0.88

Functions of the endothelial cell surface. Annu Rev Physiol (1986) 0.88

Prelesional events in atherogenesis. Colocalization of apolipoprotein B, unesterified cholesterol and extracellular phospholipid liposomes in the aorta of hyperlipidemic rabbit. Atherosclerosis (1987) 0.87

Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Arterioscler Thromb Vasc Biol (1997) 0.86

Prelesional modifications of the vessel wall in hyperlipidemic atherogenesis. Extracellular accumulation of modified and reassembled lipoproteins. Ann N Y Acad Sci (1990) 0.86

Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster. J Submicrosc Cytol Pathol (1990) 0.84

Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro. Arterioscler Thromb Vasc Biol (2000) 0.84

Carotid-cavernous fistula in the child. Neurol Psychiatr (Bucur) (1978) 0.84

Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells. Thromb Haemost (1995) 0.84

In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels. Thromb Haemost (2000) 0.84

Temporal and topographic matrix metalloproteinase expression after vascular injury in mice. Thromb Haemost (1999) 0.84

Polymorphism of HLA in the Romanian population. Tissue Antigens (1992) 0.84

Cellular events in the development of valvular atherosclerotic lesions induced by experimental hypercholesterolemia. Atherosclerosis (1987) 0.83

Differentiated uptake and transcytosis of albumin in successive vascular segments. J Submicrosc Cytol Pathol (1988) 0.83

Enzymatic tracers in the study of vascular permeability. J Histochem Cytochem (1979) 0.83

The cerebral microvasculature of the rat: structure and luminal surface properties during early development. J Submicrosc Cytol Pathol (1988) 0.83

Intimal thickenings of human aorta contain modified reassembled lipoproteins. Atherosclerosis (1995) 0.83

Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster. Am J Pathol (1996) 0.83

Endothelial cell receptors for histamine. Ann N Y Acad Sci (1982) 0.82

Increased adhesion of human diabetic platelets to cultured valvular endothelial cells. J Submicrosc Cytol Pathol (1992) 0.82

Population and family studies of HLA-DR4 by use of oligonucleotide typing. Tissue Antigens (1992) 0.82

A novel L23-related gene 40 kb downstream of the imprinted H19 gene is biallelically expressed in mid-fetal and adult human tissues. Hum Mol Genet (1995) 0.82

Recent studies on vascular endothelium. Ann N Y Acad Sci (1976) 0.82

Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons. Thromb Haemost (1999) 0.82

Anionized and cationized hemeundecapeptides as probes for cell surface charge and permeability studies: differentiated labeling of endothelial plasmalemmal vesicles. J Cell Biol (1985) 0.81

In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins: antioxidant effect of albumin. Biochim Biophys Acta (1993) 0.81

Partial chemical characterization of the anionic sites in the basal lamina of fenestrated capillaries. Microvasc Res (1984) 0.79

Organization of the intercellular junctions in the endothelium of cardiac valves. J Submicrosc Cytol (1985) 0.79

Heart microvessels and aortic endothelial cells express the 15 kDa heart-type fatty acid-binding proteins. Eur J Cell Biol (1998) 0.79

Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia. J Thromb Haemost (2013) 0.79

Posterior fossa extradural hematomas in children: report of nine cases. Childs Nerv Syst (1993) 0.79

Enhanced prothrombin and intrinsic factor X activation on blood platelets from diabetic patients. Thromb Haemost (1993) 0.78